VEGF-C Recombinant Protein

CAT:
209-300-079
Size:
20 µg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
VEGF-C Recombinant Protein - image 1

VEGF-C Recombinant Protein

  • Description:

    VEGF-C, also known as Vascular Endothelial Growth Factor Related Protein (VRP), is a recently discovered VEGF growth factor family member that is most closely related to VEGF-D. The human VEGF-C cDNA encodes a pre-pro-protein of 416 amino acids residues. It is almost identical to the mouse VEGF-C protein. Similar to VEGF-D, VEGF-C has a VEGF homology domain spanning the middle third of the precursor molecule and long N- and C-terminal extensions. In adults, VEGF-C is highly expressed in heart, placenta, ovary and small intestine. Recombinant human VEGF-C, lacking the N- and C-terminal extensions and containing only the middle VEGF homology domain, forms primarily non-covalently linked dimers. This protein is a ligand for both VEGFR-2/KDR and VEGFR-3/FLT-4. Since VEGFR-3 is strongly expressed in lymphatic endothelial cells, it has been postulated that VEGF-C is involved in the regulation of the growth and/or differentiation of lymphatic endothelium. Although recombinant human VEGF-C is also a mitogen for vascular endothelial cells, it is much less potent than VEGF-A. The recombinant human VEGF-C contains 121 amino acids residues and was fused to a His-tag (6x His) at the C-terminal end. As a result of glycosylation VEGF-C migrates as an 18-24 kDa protein in SDS-PAGE under reducing conditions.
  • Synonyms:

    vascular endothelial growth factor C; VEGFC; VRP; Flt4-L; VEGF c
  • CAS Number:

    9000-83-3
  • NCBI Gene ID:

    7424
  • UniProt:

    P49767
  • Accession Number:

    NP_005420.1
  • Accession Number mRNA:

    NM_005429.2
  • Gene Location:

    11q13
  • Host:

    Insect Cells
  • Origin Species:

    Human
  • Species Reactivity:

    Human
  • Tag:

    His-Tag
  • Sequence:

    DPTEETIKFAAAHYNTEILKSIDNEWRKTQCMPREVCIDVGKEFGVATNTFFKPPCVSVYRCGGCCNSEGLQCMNTSTSYLSKTLFEITVPLSQGPKPVTISFANHTSCRCMSKLHHHHHH
  • Detection Range:

    The biological activity was determined (i) by the ability to induce VEGFR-3/FLT-4 receptor phosphorylation in PAEC/VEGFR-3 cells and (ii) the VEGF-C-induced proliferation of primary human dermal lymphatic endothelial cells (HDLEC).
  • Purity:

    > 90% by SDS-PAGE
  • Length:

    121
  • Form:

    Lyophilized
  • Buffer:

    Water
  • Reconstitution:

    The lyophilized VEGF-C is soluble in water and most aqueous buffers. The lyophilized VEGF-C should be reconstituted in PBS or medium to a concentration not lower than 50 µg/ml.
  • Molecular Weight:

    18.0-24.0 kDa
  • Shipping Conditions:

    Room Temperature
  • Storage Conditions:

    Lyophilized samples are stable for more than six months at -20°C to -70°C. Reconstituted VEGF-C should be stored in working aliquots at -20°C. Avoid repeated freeze-thaw cycles.
  • N Terminal Sequence:

    DPTEETI